Takayuki Yakushijin Selected Research

Takayuki Yakushijin Research Topics

Disease

22	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 06/2003
19	Chronic Hepatitis C 05/2019 - 03/2006
15	Infections 01/2022 - 08/2006
7	Neoplasms (Cancer) 12/2022 - 06/2003
6	Fibrosis (Cirrhosis) 10/2022 - 05/2012
5	Liver Cirrhosis (Hepatic Cirrhosis) 10/2022 - 02/2014
5	Chronic Hepatitis B 07/2015 - 05/2008
4	Hepatitis 07/2019 - 01/2006
4	Hepatitis C 05/2019 - 03/2011
4	Virus Diseases (Viral Diseases) 11/2015 - 03/2006
3	Neoplasm Metastasis (Metastasis) 03/2019 - 02/2015
3	Chronic Hepatitis (Chronic Active Hepatitis) 05/2012 - 01/2009
2	Disease Progression 02/2022 - 05/2021
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2020
2	Anemia 03/2015 - 09/2006
2	Non-alcoholic Fatty Liver Disease 10/2013 - 01/2013
2	Carcinogenesis 05/2012 - 05/2009
2	Hepatitis B 05/2012 - 01/2009
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Hypertension (High Blood Pressure) 02/2021
1	Polyps 02/2021
1	Hemorrhage 02/2021
1	Hyperlipidemias (Hyperlipidemia) 02/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Hyponatremia 01/2021
1	Portal Hypertension 09/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Adenosquamous Carcinoma 03/2019
1	Synovial Sarcoma (Synovioma) 09/2016
1	Liver Neoplasms (Liver Cancer) 09/2016
1	Hyperbilirubinemia 03/2016
1	Crohn Disease (Crohn's Disease) 04/2015

Drug/Important Bio-Agent (IBA)

16	Ribavirin (Virazole)FDA LinkGeneric 12/2017 - 09/2006
13	Antiviral Agents (Antivirals)IBA 10/2022 - 01/2009
13	InterferonsIBA 05/2019 - 09/2006
7	Fetal Proteins (Fetoprotein)IBA 12/2022 - 07/2014
5	Lamivudine (Epivir)FDA Link 05/2012 - 05/2008
4	Sorafenib (BAY 43-9006)FDA Link 04/2021 - 09/2016
3	atezolizumabIBA 07/2022 - 02/2022
3	Bevacizumab (Avastin)FDA Link 07/2022 - 02/2022
3	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2013
3	CytokinesIBA 01/2022 - 08/2006
3	DNA (Deoxyribonucleic Acid)IBA 07/2019 - 05/2012
3	sofosbuvir drug combination ledipasvirIBA 08/2018 - 12/2017
3	SofosbuvirIBA 08/2018 - 11/2015
3	SimeprevirIBA 07/2017 - 03/2016
3	NucleotidesIBA 11/2015 - 01/2009
3	entecavir FDA Link 07/2015 - 01/2009
3	Alanine Transaminase (SGPT)IBA 04/2013 - 01/2006
3	lipoarabinomannan (LAM)IBA 05/2012 - 05/2008
2	lenvatinibIBA 07/2022 - 09/2020
2	Immune Checkpoint InhibitorsIBA 03/2022 - 01/2020
2	Growth Differentiation Factor 15IBA 01/2022 - 01/2022
2	BilirubinIBA 09/2020 - 03/2016
2	ledipasvirIBA 08/2018 - 11/2015
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2011
2	telaprevirIBA 07/2017 - 03/2015
2	RNA (Ribonucleic Acid)IBA 01/2017 - 03/2012
2	Inosine Triphosphate (ITP)IBA 03/2016 - 03/2014
2	Hepatitis B e AntigensIBA 07/2015 - 05/2012
2	NucleosidesIBA 07/2015 - 01/2009
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 07/2015 - 06/2008
2	Hemoglobins (Hemoglobin)IBA 03/2015 - 09/2006
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2014 - 02/2014
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 04/2013 - 06/2012
2	Pharmaceutical PreparationsIBA 03/2012 - 01/2009
2	adefovir dipivoxil (Hepsera)FDA Link 01/2009 - 01/2009
1	Prothrombin (Factor II)IBA 12/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2022
1	Interleukin-6 (Interleukin 6)IBA 02/2022
1	RamucirumabIBA 04/2021
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2021
1	Dihydrotachysterol (AT 10)IBA 02/2021
1	SodiumIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Vitamin K 2 (Vitamin K2)IBA 01/2021
1	thiamine triphosphorate (TTP)IBA 01/2021
1	Vitamin K FDA Link 01/2021
1	menatetrenoneIBA 01/2021
1	AlbuminsIBA 09/2020
1	folfirinoxIBA 03/2019
1	GadoliniumIBA 11/2017
1	gadolinium ethoxybenzyl DTPA FDA Link 11/2017
1	Pentetic Acid (DTPA)FDA LinkGeneric 11/2017
1	Messenger RNA (mRNA)IBA 09/2016
1	Branched-Chain Amino AcidsIBA 09/2016
1	PyrophosphatasesIBA 03/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2015

Therapy/Procedure

21	Therapeutics 03/2022 - 09/2006
7	Drug Therapy (Chemotherapy) 07/2022 - 06/2012
3	Radiofrequency Ablation 12/2022 - 07/2010
2	Radiotherapy 12/2013 - 06/2012
1	Immunotherapy 02/2022
1	Surgical Instruments (Clip) 02/2021
1	Molecular Targeted Therapy 01/2021
1	Arterial Switch Operation 01/2018
1	Retreatment 07/2017
1	Metastasectomy 09/2016
1	Adjuvant Chemotherapy 09/2016